Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy?
The XXL trial represents the first prospective validation of “biological downstaging” in liver transplantation (LT) for hepatocellular carcinoma. The aim of this study was to compare the Padua downstaging protocol to the XXL protocol in terms of downstaging failure rates and patient outcome. A total...
Main Authors: | Alessandro Vitale, Federica Scolari, Alessandra Bertacco, Enrico Gringeri, Francesco D’Amico, Domenico Bassi, Francesco Enrico D’Amico, Paolo Angeli, Patrizia Burra, Quirino Lai, Umberto Cillo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/10/2406 |
Similar Items
-
Hepatosellüler karsinomada bridging veya downstaging sonrası karaciğer transplantasyonu ile direkt transplantasyon stratejilerinin sağkalım üzerine etkilerinin karşılaştırılması
by: Tuğsan BALLI, et al.
Published: (2019-12-01) -
The New TNM Staging System for Thyroid Cancer and the Risk of Disease Downstaging
by: Claudio Casella, et al.
Published: (2018-09-01) -
Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study
by: Alessandro Beleù, et al.
Published: (2019-02-01) -
Efficacy of preoperative chemoradiotherapy in downstaging rectal cancer and its impact on the long-term outcome
by: Janaki Gururajachar Manur, et al.
Published: (2019-01-01) -
Pilot Study of a Resource-Appropriate Strategy for Downstaging Breast Cancer in Rural Uganda
by: Alphonsus Matovu, et al.
Published: (2016-05-01)